用免疫调节化合物治疗结核病的辅助疗法的进展
Jie Mi1, Xueqiong Wu1, Jianqin Liang2
1Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, China.
本综述探讨了结核病 (TB) 的免疫疗法化合物,重点关注免疫调节剂和重新用途的药物. 它强调了对宿主导结核病治疗的进展和未来方向.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 是一种慢性细菌和免疫疾病,受 Mycobacterium tuberculosis (Mtb) 致病性和宿主免疫的影响.
- 患者的免疫状况显著影响结核病的发生,发展和预后.
- 有效的免疫疗法可以调节抗结核病免疫反应,抑制mtb,并帮助康复.
研究的目的:
- 审查结核病免疫治疗化合物的研究进展.
- 涵盖免疫调节化合物和用于结核病治疗的重用药物.
- 确定结核病免疫疗法的挑战和未来研究途径.
主要方法:
- 关于结核病免疫疗法的科学研究的文献综述.
- 对免疫调节化合物的研究分析.
- 检查用于结核病治疗的重用药物的研究.
主要成果:
- 对结核病免疫治疗剂的当前研究的汇编.
- 关键化合物和药物类别的识别显示出有前途.
- 对调节宿主免疫反应对Mtb.的进展的摘要.
结论:
- 免疫疗法通过调节宿主免疫力,为结核病治疗提供了一个有希望的策略.
- 需要进一步的研究来应对现有的挑战,并开发新的宿主导疗法.
- 这一审查为开发新的结核病免疫治疗剂提供了基础.
更多相关视频
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
相关概念视频
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
